← Leaderboards
Barry Ira Freedman
Wake Forest University Health Sciences
$20,046,491
Attributed
$29,064,978
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,064,978 · 14
By mechanism
R01$17,789,949 · 7
U01$10,680,456 · 2
M01$594,573 · 5
Top collaborators
- Robert J Stratta12 shared
- David M Reboussin11 shared
- Donald W. Bowden10 shared
- Jasmin Divers10 shared
- Joseph A Maldjian5 shared
- Nicholette D. Allred2 shared
- Lijun Ma2 shared
- Carl D Langefeld1 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Amber Reeves-Daniel$1,060,156
- Jasmin Divers$6,078,723
- James C. Rose$15,077,307
- Robert J Stratta$1,878,762
- Lijun Ma$652,169
Others in their field
Top investigators on “African American”
- Daniel C Ralph · Cornell University$89,901,072
- Roger T Howe · University Of California-Berkeley$89,901,072
- James D Crapo · University Of Colorado Denver$80,593,932
- Laurence H Baker · University Of Michigan At Ann Arbor$80,299,268
- William J. Blot · Vanderbilt University$71,101,682
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$70,204,880
Research focus
African AmericanGenotypeGeneticEuropeanAmericanGenesSamplingBaseVariantKidneyReportingRepositoryResourcesRelative (Related Person)PredispositionEnd Stage Renal FailureResearch PersonnelRisk VariantAfricanRenal FunctionLinkForestApolipoproteinsDesign
Grant awards (61)
14/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Scientific Data Research Center$1,177,380
U01 · FY2025 · DK · contact PI
Trans-omics Analysis of African American Deceased Donor Kidneys for Transplant Outcomes.$662,465
R01 · FY2025 · DK · contact PI
14/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Scientific Data Research Center$1,077,381
U01 · FY2024 · DK · contact PI
Trans-omics Analysis of African American Deceased Donor Kidneys for Transplant Outcomes.$641,873
R01 · FY2024 · DK · contact PI
14/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Scientific Data Research Center$901,035
U01 · FY2023 · DK · contact PI
Wake Forest APOLLO Scientific and Data Research Center$750,000
U01 · FY2022 · DK · contact PI
Wake Forest APOLLO Scientific and Data Research Center$750,000
U01 · FY2021 · DK · contact PI
Wake Forest APOLLO Scientific and Data Research Center$209,250
U01 · FY2021 · DK · contact PI
Wake Forest APOLLO Scientific and Data Research Center$50,000
U01 · FY2020 · DK · contact PI
Wake Forest APOLLO Scientific and Data Research Center$750,000
U01 · FY2019 · DK · contact PI
Wake Forest APOLLO Scientific and Data Research Center$200,000
U01 · FY2019 · DK · contact PI
Wake Forest APOLLO Scientific and Data Research Center$150,000
U01 · FY2019 · DK · contact PI
Wake Forest APOLLO Scientific and Data Research Center$750,000
U01 · FY2018 · DK · contact PI
Genetic Determinants of Renal Transplant Survival from African American Donors$141,391
R01 · FY2018 · MD
Wake Forest APOLLO Scientific and Data Research Center$750,000
U01 · FY2017 · DK · contact PI
Genetic Determinants of Renal Transplant Survival from African American Donors$384,720
R01 · FY2017 · MD
Genetic Determinants of Renal Transplant Survival from African American Donors$394,012
R01 · FY2016 · MD
Subclinical CVD in African American Type 2 Diabetics$363,568
R01 · FY2016 · DK · contact PI
An Integrative Genomic Approach to APOL1-Associated Nephropathy.$530,499
R01 · FY2015 · DK · contact PI
Cerebrovascular Disease and Cognitive Performance in African Americans$500,452
R01 · FY2015 · NS · contact PI
Subclinical CVD in African American Type 2 Diabetics$477,842
R01 · FY2015 · DK · contact PI
Genetic Determinants of Renal Transplant Survival from African American Donors$402,927
R01 · FY2015 · MD
An Integrative Genomic Approach to APOL1-Associated Nephropathy.$592,127
R01 · FY2014 · DK · contact PI
Cerebrovascular Disease and Cognitive Performance in African Americans$550,368
R01 · FY2014 · NS · contact PI
Genetic Determinants of Renal Transplant Survival from African American Donors$385,000
R01 · FY2014 · MD
Subclinical CVD in African American Type 2 Diabetics$381,615
R01 · FY2014 · DK · contact PI
An Integrative Genomic Approach to APOL1-Associated Nephropathy.$572,026
R01 · FY2013 · DK · contact PI
Cerebrovascular Disease and Cognitive Performance in African Americans$558,818
R01 · FY2013 · NS · contact PI
Subclinical CVD in African American Type 2 Diabetics$434,823
R01 · FY2013 · DK · contact PI
An Integrative Genomic Approach to APOL1-Associated Nephropathy.$623,493
R01 · FY2012 · DK · contact PI
Cerebrovascular Disease and Cognitive Performance in African Americans$594,957
R01 · FY2012 · NS · contact PI
Natural History of MYH9-Associated Nephropathy$529,038
R01 · FY2012 · DK · contact PI
Subclinical CVD in African American Type 2 Diabetics$461,357
R01 · FY2012 · DK · contact PI
An Integrative Genomic Approach to APOL1-Associated Nephropathy.$732,862
R01 · FY2011 · DK · contact PI
Cerebrovascular Disease and Cognitive Performance in African Americans$609,418
R01 · FY2011 · NS · contact PI
Natural History of MYH9-Associated Nephropathy$529,859
R01 · FY2011 · DK · contact PI
Natural History of MYH9-Associated Nephropathy$621,533
R01 · FY2010 · DK · contact PI
Subclinical CVD in African American Type 2 Diabetics$600,853
R01 · FY2010 · DK · contact PI
SUBCLINICAL CVD IN AFRICAN AMERICAN TYPE 2 DIABETICS$105,581
M01 · FY2010 · RR · contact PI
Subclinical CVD in African American Type 2 Diabetics$645,731
R01 · FY2009 · DK · contact PI
Natural History of MYH9-Associated Nephropathy$621,577
R01 · FY2009 · DK · contact PI
Genetic Analysis of African American Hypertensive End-Stage Renal Disease$411,314
R01 · FY2009 · DK · contact PI
GENETICS OF AFRICAN AMERICAN TYPE 2 DIABETES HIGH BLOOD PRESSURE$157,191
M01 · FY2009 · RR · contact PI
SUBCLINICAL CVD IN AFRICAN AMERICAN TYPE 2 DIABETICS$94,898
M01 · FY2009 · RR · contact PI
Subclinical CVD in African American Type 2 Diabetics$613,433
R01 · FY2008 · DK · contact PI
Genetic Analysis of African American Hypertensive End-Stage Renal Disease$381,539
R01 · FY2008 · DK · contact PI
GENETICS OF AFRICAN AMERICAN TYPE 2 DIABETES$184,258
M01 · FY2008 · RR · contact PI
SUBCLINICAL CVD IN AFRICAN AMERICAN TYPE 2 DIABETICS$52,645
M01 · FY2008 · RR · contact PI
Subclinical CVD in African American Type 2 Diabetics$542,725
R01 · FY2007 · DK · contact PI
Genetic Analysis of African American Hypertensive End-Stage Renal Disease$398,847
R01 · FY2007 · DK · contact PI
Genetic Analysis of African American Hypertensive End-Stage Renal Disease$430,727
R01 · FY2006 · DK · contact PI
Continuation of the FIND Study$39,608
U01 · FY2006 · DK · contact PI
Continuation of the FIND Study$75,000
U01 · FY2005 · DK
RENAL FAILURE GENES IN THE SOUTHEASTERN US$479,000
U01 · FY2004 · DK
RENAL FAILURE GENES IN THE SOUTHEASTERN US$443,007
U01 · FY2003 · DK
RENAL FAILURE GENES IN THE SOUTHEASTERN US$518,000
U01 · FY2002 · DK
RENAL FAILURE GENES IN THE SOUTHEASTERN US$1,043,000
U01 · FY2001 · DK
RENAL FAILURE GENES IN THE SOUTHEASTERN US$35,000
U01 · FY2001 · DK
GENETIC ANALYSIS OF HUMAN HYPERTENSIVE ESRD$23,211
R01 · FY2001 · HL
RENAL FAILURE GENES IN THE SOUTHEASTERN US$532,795
U01 · FY2000 · DK
GENETIC ANALYSIS OF HUMAN HYPERTENSIVE ESRD$442,949
R01 · FY2000 · HL